Sanofi SA (NASDAQ:SNY) Q3 2022 Results Conference Call October 28, 2022 8:30 AM ET Company Participants Eva Schaefer-Jansen - Head, IR Paul Hudson - CEO Bill Sibold - EVP, Specialty Care; President, North America Thomas Triomphe - EVP, Vaccines Olivier Charmeil - EVP, General Medicines Julie Van Ongevalle - EVP, Consumer Healthcare Jean-Baptiste de Chatillon - CFO John Reed - EVP & Global Head, Research & Development Roy Papatheodorou - EVP, General Counsel & Head of Legal, Ethics & Business Brendan OÂ'Call ...